Decas Botanical Synergies, LLC. Company Profile

14:27 EST 20th December 2014 | BioPortfolio

Headquartered in Carver, Massachusetts, Decas Botanical Synergies, a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of patented, value-added fruit-derived ingredients for the dietary supplement, functional foods, animal feed and nutrition, personal care and cosmetics, and oral health industries. Specializing in cranberries, DBS’s Fruitaceutical® products are rich in natural bioflavonoid complexes, which provide manufacturers with powerful antioxidant, antimicrobial and nutritional properties, and a natural colorant for a broad variety of applications. Decas powders, extracts and oils offer cost-effective and natural options to enhance the taste, color, function and nutritional content of products. For additional information, please visit www.decasbotanical.com.


News Articles [60 Associated News Articles listed on BioPortfolio]

Malaysian botanical drug developer seeks $300 mln Nasdaq listing

KUALA LUMPUR, July 8 (Reuters) - Malaysia's state-owned agri-business conglomerate FELDA is looking to tap growing demand for botanical drugs and treatments with a planned $300 million listing of a li...

Intrepid scientific explorer recounts lifetime of work and adventure in Amazon

(The New York Botanical Garden) In That Glorious Forest: Exploring the Plants and Their Indigenous Uses in Amazonia, Sir Ghillean Prance chronicles nearly five decades of experience as one of the semi...

Medtronic Covets Covidien, But It Could Do So Much Better

By Amit H. Shah:On June 15, Medtronic (MDT) announced its intention to acquire Covidien (COV) for $43 billion, which represents a 30% premium to Covidien's stock price before the announcement. Medtron...

UPDATE 4-Electrolux takes on Whirlpool in U.S. with $3.3 bln GE Appliances buy

* Values unit at 7.0-7.3 X 2014 EBITDA, ex synergies of $300 mln

UPDATE 3-Electrolux takes on Whirlpool in U.S. with $3.3 bln GE Appliances buy

* Values unit at 7.0-7.3 X 2014 EBITDA, ex synergies of $300 mln

UPDATE 2-Electrolux takes on Whirlpool in U.S. with $3.3 bln GE Appliances buy

* Values unit at 7.0-7.3 X 2014 EBITDA, ex synergies of $300 mln

UPDATE 5-Electrolux takes on Whirlpool in U.S. with $3.3 bln GE Appliances buy

* Values unit at 7.0-7.3 X 2014 EBITDA, ex synergies of $300 mln

Gaia Herbs® Invited to Present at U.S. Pharmacopeial Convention Meeting October 23-24

BREVARD, N.C., Oct. 23, 2014 /PRNewswire/ -- Gaia Herbs® has been invited to present at a U.S. Pharmacopeial Convention (USP) workshop hosted today and tomorrow, October 23-24, at the agency...

PubMed Articles [66 Associated PubMed Articles listed on BioPortfolio]

The flexible recruitment of muscle synergies depends on the required force generating capability.

o simplify redundant motor control, the central nervous system (CNS) may modularly organize and recruit groups of muscles as "muscle synergies". However, smooth and efficient movements are expected to...

Chemometric Analysis for Identification of Botanical Raw Materials for Pharmaceutical Use: A Case Study Using Panax notoginseng.

The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug produ...

Effective force control by muscle synergies.

Muscle synergies have been proposed as a way for the central nervous system (CNS) to simplify the generation of motor commands and they have been shown to explain a large fraction of the variation in ...

Coordination among thigh muscles including the vastus intermedius and adductor magnus at different cycling intensities.

Although many studies have been focused on muscle synergies in the lower limbs, synergies of the thigh muscles during cycling have not been investigated in detail. We examined synergies of the thigh m...

Biopreparedness and Public Health: Exploring Synergies Iris Hunger , Vladan Radosavljevic , Goran Belojevic , Lisa Rotz , eds., Biopreparedness and Public Health: Exploring Synergies . Dordrecht, The Netherlands : Springer , 2013 , 225 pages, ISBN: 978-9400752993 . Softcover $65.66 .

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Capecitabine is a chemotherapeutic that has been approved for use in breast and colorectal cancers. The advantages of capecitabine are that (1) it is an oral drug; and (2) it is less toxi...

Efficacy of Myalgesin™ to Support Joint Function in Patients With Knee Osteoarthritis

Myalgesin is a botanical preparation consisting of celery seed extract,extract of dried Boswellia serrata, and dried extract of Phellodendron bark. Component of these extracts have been sh...

Study to Evaluate the Effect of Botanical Dietary Supplements on Inflammation in Healthy People

The purpose of the study is to evaluate the effect of botanical dietary supplements on inflammation in healthy people with different genetic responses to inflammation.

Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury

OBJECTIVES: I. Assess the ability of patients with and without sensorimotor loss below the thoracic spinal cord injury to execute coordinated whole-limb synergies sufficient for walking w...

Botanical/Drug Interactions in HIV: Glucuronidation

A series of clinical studies will be conducted in normal, healthy adult volunteers to evaluate the potential for alterations in the pharmacokinetics of anti HIV drugs when botanicals/nutri...

Companies [60 Associated Companies listed on BioPortfolio]

Decas Botanical Synergies (DBS)

Headquartered in Carver, Massachusetts, Decas Botanical Synergies (DBS), a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of proprietary, ...

Decas Botanical Synergies, LLC. (DBS)

Headquartered in Carver, Massachusetts, Decas Botanical Synergies (DBS), a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of proprietary, ...

Decas Botanical Synergies, LLC.

Headquartered in Carver, Massachusetts, Decas Botanical Synergies, a subsidiary of Decas Cranberry Products, Inc., is a developer, manufacturer and marketer of patented, value-add...

Corporate Synergies Group, Inc.

Corporate Synergies is an established leader in the employee benefits industry. A privately held employee benefits broker and consultant firm serving the middle market, Corporate ...

Botanical Enterprises, Inc

Botanical Enterprises, Inc. (BEI) has been active in the field of botanical medicine since 1992 and was formally incorporated in Delaware in 1997. It is structured as a privately held "virtual" equity...

More Information about "Decas Botanical Synergies, LLC." on BioPortfolio

We have published hundreds of Decas Botanical Synergies, LLC. news stories on BioPortfolio along with dozens of Decas Botanical Synergies, LLC. Clinical Trials and PubMed Articles about Decas Botanical Synergies, LLC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Decas Botanical Synergies, LLC. Companies in our database. You can also find out about relevant Decas Botanical Synergies, LLC. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record